Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Aug 4;9(8):833.
doi: 10.3390/nu9080833.

Serum Iron:Ferritin Ratio Predicts Healthy Body Composition and Reduced Risk of Severe Fatty Liver in Young Adult Women

Affiliations
Comparative Study

Serum Iron:Ferritin Ratio Predicts Healthy Body Composition and Reduced Risk of Severe Fatty Liver in Young Adult Women

Nindy Sabrina et al. Nutrients. .

Abstract

Dysregulated iron metabolism is associated with altered body composition and nonalcoholic fatty liver disease (NAFLD); however, mechanisms underlying this association remain undefined. We investigated this association in 117 women. Middle-aged women (≥45 years old (y)) were heavier and had lower serum iron, higher serum hepcidin, ferritin, and severe NAFLD incidence than young adult women (<45 y). Age-adjusted linear regression analysis revealed that young adult women with the highest serum iron:ferritin ratio (Tertile 3) had a 5.08-unit increased percentage of muscle mass [β = 5.08 (1.48-8.68), p < 0.001] and a 1.21-unit decreased percentage visceral fat mass [β = -1.21 (-2.03 to -0.39), p < 0.001] compared with those with the lowest serum iron:ferritin ratio (Tertile 1; reference). The iron:ferritin dietary pattern, characterized by high consumption of beef, lamb, dairy products, fruits, and whole grains, and low consumption of refined carbohydrates (rice, noodles, and bread and pastries), and deep- and stir-fried foods, predicted a 90% [odds ratio: 0.10, 95% confidence interval: 0.02-0.47, p < 0.001] reduced risk of mild vs. moderate and severe NAFLD in young adult women. Our findings suggest that the serum iron:ferritin ratio more accurately predicts body composition and reduced risk of severe fatty liver progression in young adult women compared to middle-aged women.

Keywords: body composition; dietary pattern; non-alcoholic fatty liver disease; serum ferritin; serum iron.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Directed acyclic graph of reduced rank regression. ALT, alanine aminotransferase; LDL-C, low-density lipoprotein cholesterol; CML, Nε-(carboxymethyl)lysine.
Figure 2
Figure 2
Age-adjusted linear regression analyses of serum iron:ferritin ratio and body compositions according to the tertile group of serum iron:ferritin ratio in young adult (n = 65) and middle-aged (n = 52) women. (A) Serum iron:ferritin ratio to predict skeletal muscle mass in women <45 years; (B) Serum iron:ferritin ratio to predict visceral fat mass in women <45 years; (C) Serum iron:ferritin ratio to predict skeletal muscle mass in women ≥45 years; (D) Serum iron:ferritin ratio to predict visceral fat mass in women ≥45 years. ** p < 0.01, and *** p < 0.001 indicate statistical significance.
Figure 3
Figure 3
Age-adjusted odds ratio (OR) and 95% confidence interval (CI) for predicting mild vs. moderate and severe fatty liver according to the serum iron:ferritin-specific dietary pattern score determined using reduced rank regression. ** p < 0.01 indicate statistical significance.

References

    1. Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global Epidemiology of Non-Alcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence and Outcomes. Hepatology. 2016 doi: 10.1002/hep.28431. - DOI - PubMed
    1. Abenavoli L., Milic N., Di Renzo L., Preveden T., Medic-Stojanoska M., De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J. Gastroenterol. 2016;22:7006–7016. doi: 10.3748/wjg.v22.i31.7006. - DOI - PMC - PubMed
    1. Dongiovanni P., Fracanzani A.L., Fargion S., Valenti L. Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. J. Hepatol. 2011;55:920–932. doi: 10.1016/j.jhep.2011.05.008. - DOI - PubMed
    1. George D.K., Goldwurm S., MacDonald G.A., Cowley L.L., Walker N.I., Ward P.J., Jazwinska E.C., Powell L.W. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 1998;114:311–318. doi: 10.1016/S0016-5085(98)70482-2. - DOI - PubMed
    1. Deugnier Y.M., Loreal O., Turlin B., Guyader D., Jouanolle H., Moirand R., Jacquelinet C., Brissot P. Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 1992;102:2050–2059. doi: 10.1016/0016-5085(92)90331-R. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources